{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:35:28Z","timestamp":1791408928418,"version":"4.3.3"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"vor","delay-in-days":1461,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2014]]},"DOI":"10.1038\/ki.2013.344","type":"journal-article","created":{"date-parts":[[2013,9,25]],"date-time":"2013-09-25T12:46:27Z","timestamp":1380113187000},"page":"457-470","source":"Crossref","is-referenced-by-count":99,"title":["Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy"],"prefix":"10.1016","volume":"85","author":[{"given":"Hassan","family":"Izzedine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Mangier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Ory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelhia","family":"Sendeyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khedidja","family":"Bouachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Audard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"P\u00e9choux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean C.","family":"Soria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Massard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rastilav","family":"Bahleda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Bourry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Khayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Baumelou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Ollero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Pawlak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djillali","family":"Sahali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2013.344_bb0010","doi-asserted-by":"crossref","first-page":"F1656","DOI":"10.1152\/ajprenal.00275.2009","article-title":"The balance of autocrine VEGF-A and VEGF-C determines podocyte survival","volume":"297","author":"Muller-Deile","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2013.344_bb0015","doi-asserted-by":"crossref","first-page":"F422","DOI":"10.1152\/ajprenal.00448.2005","article-title":"Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP","volume":"291","author":"Guan","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2013.344_bb0020","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nrclinonc.2009.130","article-title":"An overview of small-molecule inhibitors of VEGFR signaling","volume":"6","author":"Ivy","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1038\/ki.2013.344_bb0025","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMra0706596","article-title":"Tumor angiogenesis","volume":"358","author":"Kerbel","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2013.344_bb0030","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2353\/ajpath.2006.050834","article-title":"Vascular endothelial growth factor localization in the adult","volume":"168","author":"Maharaj","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1038\/ki.2013.344_bb0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1096\/fasebj.13.1.9","article-title":"Vascular endothelial growth factor (VEGF) and its receptors","volume":"13","author":"Neufeld","year":"1999","journal-title":"FASEB J"},{"key":"10.1038\/ki.2013.344_bb0040","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/359843a0","article-title":"Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis","volume":"359","author":"Shweiki","year":"1992","journal-title":"Nature"},{"key":"10.1038\/ki.2013.344_bb0045","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1126\/science.1079666","article-title":"PDGFRA activating mutations in gastrointestinal stromal tumors","volume":"299","author":"Heinrich","year":"2003","journal-title":"Science"},{"key":"10.1038\/ki.2013.344_bb0050","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer","volume":"350","author":"Hurwitz","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2013.344_bb0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-642-01222-8_1","article-title":"Imatinib mesylate","volume":"184","author":"Waller","year":"2010","journal-title":"Recent Results Cancer Res"},{"key":"10.1038\/ki.2013.344_bb0060","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/107327480701400312","article-title":"Spectrum of activity and mechanism of action of VEGF\/PDGF inhibitors","volume":"14","author":"Homsi","year":"2007","journal-title":"Cancer Control"},{"key":"10.1038\/ki.2013.344_bb0065","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","article-title":"VEGF inhibition and renal thrombotic microangiopathy","volume":"358","author":"Eremina","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2013.344_bb0070","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00281-007-0094-z","article-title":"Minimal change nephropathy and focal segmental glomerulosclerosis","volume":"29","author":"Mathieson","year":"2007","journal-title":"Semin Immunopathol"},{"key":"10.1038\/ki.2013.344_bb0075","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1681\/ASN.2010020218","article-title":"NF-kappaB in renal inflammation","volume":"21","author":"Sanz","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.344_bb0080","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1128\/MCB.01152-07","article-title":"RelA Ser276 phosphorylation is required for activation of a subset of NF-kappaB-dependent genes by recruiting cyclin-dependent kinase 9\/cyclin T1 complexes","volume":"28","author":"Nowak","year":"2008","journal-title":"Mol Cell Biol"},{"key":"10.1038\/ki.2013.344_bb0085","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1097-2765(00)80066-0","article-title":"Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP\/p300","volume":"1","author":"Zhong","year":"1998","journal-title":"Mol Cell"},{"key":"10.1038\/ki.2013.344_bb0090","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1158\/1078-0432.CCR-09-1352","article-title":"Nuclear NF-kappaB p65 phosphorylation at serine 276 by protein kinase A contributes to the malignant phenotype of head and neck cancer","volume":"15","author":"Arun","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1038\/ki.2013.344_bb0095","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ejca.2009.11.001","article-title":"VEGF signalling inhibition-induced proteinuria: Mechanisms, significance and management","volume":"46","author":"Izzedine","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1038\/ki.2013.344_bb0100","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/ncpneph0476","article-title":"Proteinuria in a patient receiving anti-VEGF therapy for metastatic renal cell carcinoma","volume":"3","author":"Roncone","year":"2007","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1038\/ki.2013.344_bb0105","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1470-2045(07)70037-2","article-title":"Renal thrombotic microangiopathy caused by anti-VEGF-antibody treatment for metastatic renal-cell carcinoma","volume":"8","author":"Frangie","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1038\/ki.2013.344_bb0110","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/ndt\/gfl565","article-title":"Thrombotic microangiopathy and anti-VEGF agents","volume":"22","author":"Izzedine","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2013.344_bb0115","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/ndt\/gfn657","article-title":"Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib","volume":"24","author":"Bollee","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2013.344_bb0120","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1161\/CIRCRESAHA.107.150474","article-title":"Vascular endothelial cell-specific NF-kappaB suppression attenuates hypertension-induced renal damage","volume":"101","author":"Henke","year":"2007","journal-title":"Circ Res"},{"key":"10.1038\/ki.2013.344_bb0125","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/CIRCRESAHA.107.158295","article-title":"Endothelial NF-kappaB as a mediator of kidney damage: the missing link between systemic vascular and renal disease?","volume":"101","author":"Guzik","year":"2007","journal-title":"Circ Res"},{"key":"10.1038\/ki.2013.344_bb0130","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1523-1755.2005.00424.x","article-title":"NF-kappaB-dependent increase in intrarenal angiotensin II induced by proteinuria","volume":"68","author":"Takase","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.344_bb0135","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa021491","article-title":"A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer","volume":"349","author":"Yang","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2013.344_bb0140","doi-asserted-by":"crossref","first-page":"10002","DOI":"10.1074\/jbc.274.15.10002","article-title":"The role of phosphatidylinositol 3-kinase in vascular endothelial growth factor signaling","volume":"274","author":"Thakker","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.2013.344_bb0145","doi-asserted-by":"crossref","first-page":"34009","DOI":"10.1074\/jbc.M603928200","article-title":"Phosphorylation of Tyr1214 within VEGFR-2 triggers the recruitment of Nck and activation of Fyn leading to SAPK2\/p38 activation and endothelial cell migration in response to VEGF","volume":"281","author":"Lamalice","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.2013.344_bb0150","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10456-004-7960-2","article-title":"VEGF treatment induces signaling pathways that regulate both actin polymerization and depolymerization","volume":"7","author":"Gong","year":"2004","journal-title":"Angiogenesis"},{"key":"10.1038\/ki.2013.344_bb0155","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/ki.2010.64","article-title":"Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease","volume":"77","author":"Veron","year":"2010","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.344_bb0160","doi-asserted-by":"crossref","first-page":"39933","DOI":"10.1074\/jbc.M111.241620","article-title":"Vascular endothelial growth factor receptor 2 direct interaction with nephrin links VEGF-A signals to actin in kidney podocytes","volume":"286","author":"Bertuccio","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.2013.344_bb0165","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1681\/ASN.2010030295","article-title":"Glomerular structure and function require paracrine, not autocrine, VEGF-VEGFR-2 signaling","volume":"21","author":"Sison","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.344_bb0170","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.cell.2012.08.037","article-title":"Soluble FLT1 binds lipid microdomains in podocytes to control cell morphology and glomerular barrier function","volume":"151","author":"Jin","year":"2012","journal-title":"Cell"},{"key":"10.1038\/ki.2013.344_bb0175","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.neuroscience.2009.05.019","article-title":"Sorafenib inhibits nuclear factor kappa B, decreases inducible nitric oxide synthase and cyclooxygenase-2 expression, and restores working memory in APPswe mice","volume":"162","author":"Echeverria","year":"2009","journal-title":"Neuroscience"},{"key":"10.1038\/ki.2013.344_bb0180","doi-asserted-by":"crossref","first-page":"ra39","DOI":"10.1126\/scisignal.2000678","article-title":"c-mip impairs podocyte proximal signaling and induces heavy proteinuria","volume":"3","author":"Zhang","year":"2010","journal-title":"Sci Signal"},{"key":"10.1038\/ki.2013.344_bb0185","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/ki.2012.426","article-title":"Upregulation of c-mip is closely related to podocyte dysfunction in membranous nephropathy","volume":"83","author":"Sendeyo","year":"2013","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.344_bb0190","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1681\/ASN.2005101051","article-title":"Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome","volume":"17","author":"Fremeaux-Bacchi","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.344_bb0195","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1182\/blood.V98.6.1765","article-title":"Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases","volume":"98","author":"Veyradier","year":"2001","journal-title":"Blood"},{"key":"10.1038\/ki.2013.344_bb0200","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1046\/j.1523-1755.2001.00940.x","article-title":"LF15-0195 prevents the induction and inhibits the progression of rat anti-GBM disease","volume":"60","author":"Tesch","year":"2001","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.344_bb0205","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1440-1797.2007.00855.x","article-title":"Quantification of renal pathology by image analysis","volume":"12","author":"Rangan","year":"2007","journal-title":"Nephrology (Carlton)"},{"key":"10.1038\/ki.2013.344_bb0210","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1083\/jcb.57.2.551","article-title":"A technique for ultracryotomy of cell suspensions and tissues","volume":"57","author":"Tokuyasu","year":"1973","journal-title":"J Cell Biol"},{"key":"10.1038\/ki.2013.344_bb0215","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1006\/excr.1997.3739","article-title":"Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines","volume":"236","author":"Mundel","year":"1997","journal-title":"Exp Cell Res"},{"key":"10.1038\/ki.2013.344_bb0220","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/376167a0","article-title":"Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B","volume":"376","author":"Beg","year":"1995","journal-title":"Nature"},{"key":"10.1038\/ki.2013.344_bb0225","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/0092-8674(92)90554-P","article-title":"The high mobility group protein HMG I(Y) is required for NF-kappa B- dependent virus induction of the human IFN-beta gene","volume":"71","author":"Thanos","year":"1992","journal-title":"Cell"},{"key":"10.1038\/ki.2013.344_bb0230","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.molimm.2008.09.034","article-title":"C-mip interacts physically with RelA and inhibits nuclear factor kappa B activity","volume":"46","author":"Kamal","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1038\/ki.2013.344_bb0235","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S1046-2023(02)00007-5","article-title":"Characterizing transcription factor binding sites using formaldehyde crosslinking and immunoprecipitation","volume":"26","author":"Wells","year":"2002","journal-title":"Methods"},{"key":"10.1038\/ki.2013.344_bb0240","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1681\/ASN.V1281648","article-title":"Transcriptional and post-transcriptional alterations of IkappaBalpha in active minimal-change nephrotic syndrome","volume":"12","author":"Sahali","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.344_bb0245","doi-asserted-by":"crossref","first-page":"5169","DOI":"10.1128\/MCB.9.11.5169","article-title":"UV-induced DNA damage is an intermediate step in UV-induced expression of human immunodeficiency virus type 1, collagenase, c-fos, and metallothionein","volume":"9","author":"Stein","year":"1989","journal-title":"Mol Cell Biol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815561942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815561942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,6]],"date-time":"2022-03-06T21:42:41Z","timestamp":1646602961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815561942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"alternative-id":["S0085253815561942"],"URL":"https:\/\/doi.org\/10.1038\/ki.2013.344","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}